Literature DB >> 23082

Effect of some beta-adrenergic blocking drugs on the renal bloow flow in dogs.

M Abdel-Razzak.   

Abstract

Using timed collection of blood returning via the renal veins, the renal blood flow was determined in anaesthetized dogs, following the intravenous injection of 3 beta-adrenergic blockers, namely propranolol, oxprenolol and pindolol. The test drugs were given as a bolus or as an infusion, and their effects on the renal blood flow and blood pressure were studied. All the test drugs produced diminution in both the renal blood flow and blood pressure. However, these effects were variable in degree. The diminution in the renal blood flow under the influence of beta-adrenergic blockers might be explained by concomitant reduction in the cardiac output and/or blockade of the renal vasodilator beta-adrenergic receptors. An added factor might by sympathetic stimulation with consequent renal vasoconstriction in the case of blockers with intrinsic sympathomimetic activity. Beta-adrenergic blocking drugs should be given with extreme caution in cases with impaired renal function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 23082

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  4 in total

1.  Labetolol in patients with hypertension and varying degrees of renal impairment.

Authors:  E G Breen; M Lombard; A Watson; J A Keogh
Journal:  Ir J Med Sci       Date:  1984-10       Impact factor: 1.568

2.  beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.

Authors:  N K Hollenberg; D F Adams; D N McKinstry; G H Williams; L J Borucki; J M Sullivan
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.

Authors:  D Cambridge; M V Whiting; G Allan
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

Review 4.  Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.